title: Re: Carbapenemase screening - the role of routinely screening urine samples?
authors.affiliation: Chesterfield Royal Hospital Foundation Trust, Calow, Chesterfield, Derbyshire, UK.
authors.forename: M
authors.initials: M
authors.lastname: Collins
authors.affiliation: Chesterfield Royal Hospital Foundation Trust, Calow, Chesterfield, Derbyshire, UK.
authors.forename: D
authors.initials: D
authors.lastname: Holland
authors.affiliation: Chesterfield Royal Hospital Foundation Trust, Calow, Chesterfield, Derbyshire, UK. Electronic address: mweinbren1@nhs.net.
authors.forename: M
authors.initials: M
authors.lastname: Weinbren
mesh_terms: D001426:Bacterial Proteins / Q000032:analysis*; D002353:Carrier State / Q000175:diagnosis* / Q000382:microbiology; D003428:Cross Infection / Q000517:prevention & control; D018562:Disease Transmission, Infectious / Q000517:prevention & control; D006090:Gram-Negative Bacteria / Q000201:enzymology / Q000302:isolation & purification*; D016905:Gram-Negative Bacterial Infections / Q000175:diagnosis* / Q000382:microbiology; D006801:Humans; D017053:Infection Control / Q000379:methods*; D008403:Mass Screening / Q000379:methods*; D001618:beta-Lactamases / Q000032:analysis*
chemical_list: D001426:Bacterial Proteins; D001618:beta-Lactamases; C063912:carbapenemase